GB0210619D0 - HMG-COA reductase inhibitor extended release formulation - Google Patents

HMG-COA reductase inhibitor extended release formulation

Info

Publication number
GB0210619D0
GB0210619D0 GBGB0210619.3A GB0210619A GB0210619D0 GB 0210619 D0 GB0210619 D0 GB 0210619D0 GB 0210619 A GB0210619 A GB 0210619A GB 0210619 D0 GB0210619 D0 GB 0210619D0
Authority
GB
United Kingdom
Prior art keywords
hmg
coa reductase
release formulation
extended release
reductase inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0210619.3A
Other versions
GB2371748B (en
GB2371748A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Andrx Corp
Original Assignee
Andrx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrx Corp filed Critical Andrx Corp
Publication of GB0210619D0 publication Critical patent/GB0210619D0/en
Publication of GB2371748A publication Critical patent/GB2371748A/en
Application granted granted Critical
Publication of GB2371748B publication Critical patent/GB2371748B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB0210619A 1999-11-08 2000-11-03 HMG-COA reductase inhibitor extended release formulation Expired - Lifetime GB2371748B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43557699A 1999-11-08 1999-11-08
PCT/US2000/030415 WO2001034123A1 (en) 1999-11-08 2000-11-03 Hmg-coa reductase inhibitor extended release formulation

Publications (3)

Publication Number Publication Date
GB0210619D0 true GB0210619D0 (en) 2002-06-19
GB2371748A GB2371748A (en) 2002-08-07
GB2371748B GB2371748B (en) 2004-12-01

Family

ID=23728948

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0210619A Expired - Lifetime GB2371748B (en) 1999-11-08 2000-11-03 HMG-COA reductase inhibitor extended release formulation

Country Status (8)

Country Link
AU (1) AU768950B2 (en)
CA (1) CA2390301A1 (en)
DE (1) DE10085183T1 (en)
GB (1) GB2371748B (en)
HK (1) HK1050134A1 (en)
IL (1) IL149524A0 (en)
NZ (1) NZ518770A (en)
WO (1) WO2001034123A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200401227A1 (en) * 2002-03-22 2005-04-28 Рэнбакси Лабораториз Лимитед DELIVERY DELIVERY SYSTEM WITH CONTROLLED DELAY, INCLUDING PRAVASTATIN
ZA200501508B (en) * 2002-09-03 2006-10-25 Biovail Lab Inc Pharmaceuticals formulations and methods for modified release of statin drugs
AU2005305459A1 (en) * 2004-11-22 2006-05-26 Dexcel Pharma Technologies Ltd. Controlled absorption of statins in the intestine
EP2079448A2 (en) * 2006-10-10 2009-07-22 Dexcel Pharma Technologies Ltd. Improved release of statins in the intestine
EP2967060A4 (en) 2013-03-15 2016-11-23 Cedars Sinai Medical Center Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
US9289418B2 (en) 2013-03-15 2016-03-22 Cedars-Sinai Medical Center Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
WO2016025762A1 (en) 2014-08-13 2016-02-18 Cedars-Sinai Medical Center Anti-methanogenic compositions and uses thereof
US10736871B2 (en) 2015-04-01 2020-08-11 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366738A (en) * 1982-07-29 1994-11-22 Merck & Co., Inc. Controlled release drug dispersion delivery device
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US5244916A (en) * 1992-01-31 1993-09-14 The Scripps Research Institute Inhibition of respiratory burst using posttranslational modification inhibitors
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
IN176897B (en) * 1993-10-29 1996-09-28 Cadila Lab Ltd
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device

Also Published As

Publication number Publication date
NZ518770A (en) 2004-02-27
AU768950B2 (en) 2004-01-08
AU1360701A (en) 2001-06-06
GB2371748B (en) 2004-12-01
CA2390301A1 (en) 2001-05-17
GB2371748A (en) 2002-08-07
DE10085183T1 (en) 2002-10-24
IL149524A0 (en) 2002-11-10
WO2001034123A1 (en) 2001-05-17
HK1050134A1 (en) 2003-06-13

Similar Documents

Publication Publication Date Title
HUP0104258A3 (en) Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor
DK1223918T3 (en) Pharmaceutical compositions comprising an HMG-CoA reductase inhibitor
PL359820A1 (en) Hmg-coa reductase inhibitors and method
AU3368400A (en) Aerosol compositions of hmg-coa reductase inhibitors for inhibiting inflammationassociated with pulmonary disease
HK1049831A1 (en) Pyrrole derivatives as phosphodiesterase vii inhibitors
AU1530001A (en) Inhibitor compositions
EP1286702A4 (en) HMG CoA REDUCTASE INHIBITORS FOR PROMOTING ANGIOGENESIS
AU2002310798A1 (en) Pharmaceutical compositions comprising a hmg-coa reductase inhibitor
AU2003250172A1 (en) Compositions comprising hmg-coa reductase inhibitor
HK1047276A1 (en) Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors
IL132786A0 (en) Hmg-coa reductase inhibitor preparation process
GB2371748B (en) HMG-COA reductase inhibitor extended release formulation
AU4543699A (en) Multibinding inhibitors of hmg-coa reductase
AU3235100A (en) Prothease inhibitors
AU6589200A (en) Extended release formulation of etodolac
AU2001280461A1 (en) Substituted pyrrole compounds and their use as spla2 inhibitors
GB2389113B (en) B-secretase inhibitor
AU3595900A (en) Tyrosine alkoxyguanidines as integrin inhibitors
AU5762899A (en) Caspase inhibitor
HUP0201597A2 (en) Antilipemic combunations comprising hmg-coa reductase inhibitors and carnitines
HUP0105145A3 (en) Process for producing hmg-coa reductase inhibitor
AU2001269121A1 (en) Substituted amidoalkyl-uracils as parp inhibitors
HUP0301728A3 (en) Hmg-coa reductase inhibiting pharmaceutical compositions and their use
GB9911546D0 (en) Release of poorly soluble agents
AU2001228647A1 (en) Dihydrofolate reductase inhibitors

Legal Events

Date Code Title Description
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1050134

Country of ref document: HK

PE20 Patent expired after termination of 20 years

Expiry date: 20201102